Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584870 · ClinicalTrials.gov registry record · Phase 2
RN624 In Adult Patients With Chronic Low Back Pain
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 220
- Enrollment target
NCT00584870 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 220 participants.
The verdict
NCT00584870, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 220 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the analgesic efficacy of RN624 compared with placebo and compared with naproxen in the treatment of adult patients with chronic low back pain.
Interventions
- DRUG Placebo
- DRUG Naproxen
- DRUG PF-04383119 (RN624)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2007-07-05 |
| Est. Completion | 2008-09-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584870
The ClinicalTrials.gov registry entry for NCT00584870 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00584870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584870 about?
NCT00584870 is a clinical study titled "RN624 In Adult Patients With Chronic Low Back Pain". The primary objective of this study is to evaluate the analgesic efficacy of RN624 compared with placebo and compared with naproxen in the treatment of adult patients with chronic low back pain.
What is the current status of trial NCT00584870?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 220 participants. The study started on 2007-07-05. Estimated completion is 2008-09-02.
What interventions are being tested in trial NCT00584870?
The interventions under investigation include: Placebo (DRUG), Naproxen (DRUG), PF-04383119 (RN624) (DRUG).
Who is sponsoring clinical trial NCT00584870?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.